This inventor holds 5 USPTO granted patents. Top assignees: Merck + Co., Inc., Mcneil-Ppc, Inc., Other. Active years: 1997-2003.
Location History:
- Berwyn, PA (US) (1997 - 2003)
- Blue Bell, PA (US) (2003)
Company Filing History:
3 out of 4,770 
1 out of 798 
2 out of 834,453 Years Active: 1997-2003
Title: Thomas J Simon: Innovator in Colonic Adenoma Treatment
Introduction
Thomas J Simon is a notable inventor based in Berwyn, PA (US), recognized for his contributions to medical innovations, particularly in the treatment of colonic adenomas. With a total of 5 patents to his name, Simon has made significant strides in the field of healthcare.
Latest Patents
One of Simon's latest patents is a method of treating colonic adenomas. This invention focuses on retarding or preventing the transformation of a colonic adenoma into a colonic adenocarcinoma. The method involves administering a non-toxic therapeutically effective amount of NSAID to patients with familial adenomatous polyposis (FAP) or those with one or more adenomas. The specific PGHS-2 inhibiting agent is preferred for this treatment, showcasing Simon's innovative approach to cancer prevention.
Career Highlights
Throughout his career, Simon has worked with prominent companies, including Merck & Co., Inc. His experience in the pharmaceutical industry has undoubtedly contributed to his expertise in developing effective treatment methods.
Collaborations
Simon has collaborated with notable coworkers, including Jilly Evans and Stacia Kargman. Their combined efforts in research and development have further advanced the field of medical treatments.
Conclusion
Thomas J Simon's work in the treatment of colonic adenomas exemplifies the impact of innovation in healthcare. His patents and collaborations reflect a commitment to improving patient outcomes through scientific advancements.